Location: Palo Alto, CA
CIK: 0001744967 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 17, 2021
Total Value: $810M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Graphite Bio Inc | 7,431,623 | $228M | 28.2% | $30.73 | — | COM | 38870X104 |
| NKTX | Nkarta, Inc. | 2,034,703 | $64.48M | 8.0% | $29.47 | -2.2% | COM | 65487U108 |
| — | Chinook Therapeutics Inc | 3,168,388 | $44.74M | 5.5% | $15.86 | — | COM | 16961L106 |
| NVAX | Novavax, Inc. | 198,600 | $42.16M | 5.2% | $117.44 | +56.0% | Call | 670002401 |
| — | Instil Bio Inc | 2,145,395 | $41.45M | 5.1% | $23.49 | — | COM | 45783C101 |
| — | Forma Therapeutics Holdings, Inc. | 1,565,529 | $38.97M | 4.8% | $44.76 | — | COM | 34633R104 |
| CNTA | Centessa Pharmaceuticals PLC | 1,537,533 | $34.15M | 4.2% | $22.21 | — | SPONS ADS | 152309100 |
| — | Sutro BioPharma Inc | 1,675,579 | $31.15M | 3.8% | $8.61 | — | COM | 869367102 |
| RXRX | Recursion Pharmaceuticals Inc | 775,583 | $28.31M | 3.5% | $29.60 | 0.0% | COM | 75629V104 |
| — | Rain Therapeutics Inc | 1,637,308 | $25.44M | 3.1% | $15.54 | — | COM | 75082Q105 |
| JANX | Janux Therapeutics Inc. | 607,949 | $15.17M | 1.9% | $22.27 | 0.0% | COM | 47103J105 |
| — | Springworks Therapeutics Inc | 169,852 | $14M | 1.7% | $21.68 | — | COM | 85205L107 |
| ACRS | Aclaris Therapeutics, Inc. | 794,171 | $13.95M | 1.7% | $1.36 | +1568.7% | COM | 00461U105 |
| — | Iveric Bio, Inc. | 2,125,371 | $13.41M | 1.7% | $5.74 | — | COM | 46583P102 |
| — | Intercept Pharmaceuticals Inc | 640,688 | $12.79M | 1.6% | $64.16 | — | COM | 45845P108 |
| — | Elevation Oncology Inc | 932,239 | $12.65M | 1.6% | $13.57 | — | COM | 28623U101 |
| — | Allakos Inc | 146,259 | $12.49M | 1.5% | $51.45 | — | COM | 01671P100 |
| — | Bolt Biotherapeutics, Inc | 737,459 | $11.4M | 1.4% | $32.91 | — | COM | 097702104 |
| — | Syros Pharmaceuticals Inc | 2,189,199 | $10.6M | 1.3% | $7.95 | — | COM | 87184Q107 |
| — | Viracta Therapeutics Inc | 711,039 | $8.063M | 1.0% | $9.25 | — | COM | 92765F108 |
| — | Verona Pharma PLC. | 1,111,112 | $7.267M | 0.9% | $6.18 | — | SPONS ADS | 925050106 |
| — | Decibel Therapeutics Inc | 826,422 | $7.107M | 0.9% | $11.36 | — | COM | 24343R106 |
| — | Allakos Inc | 83,000 | $7.086M | 0.9% | $51.45 | — | Call | 01671P100 |
| NVAX | Novavax, Inc. | 30,160 | $6.403M | 0.8% | $117.44 | +56.0% | COM | 670002401 |
| — | Aeglea BioTherapeutics, Inc. | 883,720 | $6.151M | 0.8% | $9.25 | — | COM | 00773J103 |
| RYTM | Rhythm Pharmaceuticals Inc | 300,293 | $5.88M | 0.7% | $18.85 | +10.2% | COM | 76243J105 |
| — | BCTG Acquisition Corp | 500,000 | $5.69M | 0.7% | $10.36 | — | COM | 05492W103 |
| — | Jiya Acquisition Corp | 507,041 | $5.04M | 0.6% | $1009.74 | — | COM | 47760M102 |
| DAWN | Day One Biopharmaceuticals | 202,500 | $4.611M | 0.6% | $20.76 | 0.0% | COM | 23954D109 |
| EQ | Equillium, Inc. | 738,176 | $4.348M | 0.5% | $8.10 | -22.2% | COM | 29446K106 |
| EYPT | Eyepoint Pharmaceuticals Inc | 450,000 | $4.046M | 0.5% | $11.25 | -14.7% | COM | 30233G209 |
| — | Avadel Pharmaceuticals PLC | 549,250 | $3.696M | 0.5% | $7.17 | — | SPONS ADR | 05337M104 |
| TERN | Terns Pharmaceuticals, Inc | 289,068 | $3.544M | 0.4% | $21.92 | -22.3% | COM | 880881107 |
| — | Albireo Pharma, Inc. | 100,000 | $3.518M | 0.4% | $33.37 | — | COM | 01345P106 |
| — | Atreca Inc | 396,835 | $3.381M | 0.4% | $17.99 | — | COM | 04965G109 |
| — | Kala Pharmaceuticals Inc | 601,162 | $3.186M | 0.4% | $8.83 | — | COM | 483119103 |
| — | BCLS Acquisition Corp | 300,000 | $3.159M | 0.4% | $11.14 | — | COM | G0904B105 |
| — | Consonance HFW Acquisition Co | 300,000 | $3.12M | 0.4% | $10.47 | — | COM | G2445M129 |
| IMCR | Immunocore Holdings Limited | 64,000 | $2.499M | 0.3% | $42.58 | — | SPONS ADS | 45258D105 |
| — | Alpine Immune Sciences Inc | 275,169 | $2.477M | 0.3% | $8.79 | — | COM | 02083G100 |
| — | Odonate Therapeutics Inc | 700,421 | $2.444M | 0.3% | $14.27 | — | COM | 676079106 |
| — | Vistagen Therapeutics Inc | 732,596 | $2.308M | 0.3% | $1.96 | — | COM | 92840H202 |
| — | Lifesci Acquisition II Corp | 200,000 | $2M | 0.2% | $10.67 | — | COM | 53229E103 |
| — | Kronos Bio Inc | 78,131 | $1.871M | 0.2% | $29.87 | — | COM | 50107A104 |
| RCKT | Rocket Pharmaceuticals Inc | 40,550 | $1.796M | 0.2% | $19.67 | +120.8% | COM | 77313F106 |
| — | Allovir, Inc | 82,336 | $1.625M | 0.2% | $27.50 | — | COM | 019818103 |
| BNTX | BioNTech SE | 5,758 | $1.289M | 0.2% | $69.21 | — | SPONS ADS | 09075V102 |
| — | NGM Biopharmaceuticals, Inc. | 18,225 | $359K | 0.0% | $19.73 | — | COM | 62921N105 |
| — | Catabasis Pharmaceuticals Inc | 150,000 | $317K | 0.0% | $4.37 | — | COM | 14875P206 |
| — | Amarin Corp PLC | 25,000 | $110K | 0.0% | $4.00 | — | SPONS ADR NEW | 023111206 |